Jeremy P. Springhorn - Net Worth and Insider Trading
Jeremy P. Springhorn Net Worth
The estimated net worth of Jeremy P. Springhorn is at least $136,554 dollars as of 2024-09-20. Jeremy P. Springhorn is the Director of uniQure NV and owns about 23,756 shares of uniQure NV (QURE) stock worth over $129,589. Jeremy P. Springhorn is also the Chief Business Officer of Syros Pharmaceuticals Inc and owns about 3,500 shares of Syros Pharmaceuticals Inc (SYRS) stock worth over $6,965. Details can be seen in Jeremy P. Springhorn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeremy P. Springhorn has not made any transactions after 2024-06-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeremy P. Springhorn
Jeremy P. Springhorn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeremy P. Springhorn owns 2 companies in total, including uniQure NV (QURE) , and Syros Pharmaceuticals Inc (SYRS) .
Click here to see the complete history of Jeremy P. Springhorn’s form 4 insider trades.
Insider Ownership Summary of Jeremy P. Springhorn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| QURE | uniQure NV | 2024-06-13 | director |
| SYRS | Syros Pharmaceuticals Inc | 2019-11-12 | Chief Business Officer |
Jeremy P. Springhorn Latest Holdings Summary
Jeremy P. Springhorn currently owns a total of 2 stocks. Among these stocks, Jeremy P. Springhorn owns 23,756 shares of uniQure NV (QURE) as of June 13, 2024, with a value of $129,589 and a weighting of 94.9%. Jeremy P. Springhorn also owns 3,500 shares of Syros Pharmaceuticals Inc (SYRS) as of November 12, 2019, with a value of $6,965 and a weighting of 5.1%.
Latest Holdings of Jeremy P. Springhorn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QURE | uniQure NV | 2024-06-13 | 23,756 | 5.46 | 129,589 |
| SYRS | Syros Pharmaceuticals Inc | 2019-11-12 | 3,500 | 1.99 | 6,965 |
Holding Weightings of Jeremy P. Springhorn
Jeremy P. Springhorn Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeremy P. Springhorn has made a total of 5 transactions in uniQure NV (QURE) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in uniQure NV is the sale of 2,231 shares on June 13, 2024, which brought Jeremy P. Springhorn around $11,423.
According to the SEC Form 4 filings, Jeremy P. Springhorn has made a total of 1 transactions in Syros Pharmaceuticals Inc (SYRS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Syros Pharmaceuticals Inc is the acquisition of 2,000 shares on November 12, 2019, which cost Jeremy P. Springhorn around $99,600.
Insider Trading History of Jeremy P. Springhorn
- 1
Jeremy P. Springhorn Trading Performance
GuruFocus tracks the stock performance after each of Jeremy P. Springhorn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeremy P. Springhorn is 44.38%. GuruFocus also compares Jeremy P. Springhorn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeremy P. Springhorn within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeremy P. Springhorn's insider trading performs compared to the benchmark.
Performance of Jeremy P. Springhorn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.47 | | | | | |
| Relative Return to S&P 500(%) | 1.17 | | | | | |
Jeremy P. Springhorn Ownership Network
Jeremy P. Springhorn Owned Company Details
What does uniQure NV do?
Who are the key executives at uniQure NV?
Jeremy P. Springhorn is the director of uniQure NV. Other key executives at uniQure NV include Chief Medical Officer Walid Abi-saab , Chief Financial Officer Christian Klemt , and Chief Operating Officer Pierre Caloz .
uniQure NV (QURE) Insider Trades Summary
Over the past 18 months, Jeremy P. Springhorn made 2 insider transaction in uniQure NV (QURE) with a net sale of 4,517. Other recent insider transactions involving uniQure NV (QURE) include a net sale of 30,428 shares made by Pierre Caloz , a net sale of 19,104 shares made by Christian Klemt , and a net sale of 6,732 shares made by Robert Gut .
In summary, during the past 3 months, insiders sold 1,447 shares of uniQure NV (QURE) in total and bought 0 shares, with a net sale of 1,447 shares. During the past 18 months, 127,815 shares of uniQure NV (QURE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 127,815 shares.
uniQure NV (QURE)'s detailed insider trading history can be found in Insider Trading Tracker table.
uniQure NV Insider Transactions
Jeremy P. Springhorn Mailing Address
Above is the net worth, insider trading, and ownership report for Jeremy P. Springhorn. You might contact Jeremy P. Springhorn via mailing address: C/o Uniquire N.v., 113 Hartwell Avenue, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
